Schonfeld Strategic Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,992
| Closed | -$707K | – | 2747 |
|
|
2022
Q4 | $707K | Sell |
26,992
-70,782
| -72% | -$1.85M | 0.01% | 1328 |
|
|
2022
Q3 | $1.92M | Buy |
97,774
+85,063
| +669% | +$1.67M | 0.02% | 877 |
|
|
2022
Q2 | $223K | Buy |
+12,711
| New | +$223K | ﹤0.01% | 1757 |
|
|
2020
Q2 | – | Sell |
-4,236
| Closed | -$58K | – | 1582 |
|
|
2020
Q1 | $58K | Buy |
+4,236
| New | +$58K | ﹤0.01% | 1048 |
|
|
2018
Q2 | – | Sell |
-11,784
| Closed | -$548K | – | 1013 |
|
|
2018
Q1 | $548K | Buy |
+11,784
| New | +$548K | 0.04% | 449 |
|
|
2017
Q2 | – | Sell |
-5,018
| Closed | -$270K | – | 806 |
|
|
2017
Q1 | $270K | Buy |
+5,018
| New | +$270K | 0.03% | 490 |
|
|
2016
Q4 | – | Sell |
-3,675
| Closed | -$228K | – | 672 |
|
|
2016
Q3 | $228K | Buy |
+3,675
| New | +$228K | 0.04% | 344 |
|